Actinium Pharmaceuticals, Inc. (ATNM)

1.03 -0.03 (-2.83%) USD  |  NYAM  |  Feb 23, 14:15
More

Actinium Pharmaceuticals Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Assertio Holdings, Inc. Upgrade
Altimmune, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Avanos Medical, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade